South Korean consortium to make 500 million doses of Sputnik V vaccine
By (0)
South Korean biomedical firms and the Russian Direct Investment Fund are in discussions for the production of Sputnik V vaccines in Korea for export. File Photo by RDIF/EPA-EFE
Feb. 25 (UPI) A consortium of South Korean biomedical companies is to manufacture Russia s Sputnik V vaccine.
Industry sources in Korea said the consortium that includes firms Binex, ISU Abxis, Boryung Biopharma, Chong Kun Dang Bio, Quratis, Humendix and Andong Animal Cell Validation Support Center are in negotiations with the Russian Direct Investment Fund over specific production quantities and prices, South Korean news service EDaily reported Thursday.